Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06051305 · ClinicalTrials.gov registry record · NA
Flexible Attention Sensory Training for Youth with Chronic Pain
A NA study of Persistent Pain, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT06051305: Completed NA study of Persistent Pain, sponsored by Stanford University.
NCT06051305 is a NA study of Persistent Pain that has completed, run by Stanford University. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06051305, a NA study of Persistent Pain, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the feasibility and acceptability of gamified sensory rehabilitation training technology for children with chronic musculoskeletal pain.
Primary Outcome
Acceptability will be evaluated by examining mean promoter score (measured on 10-point Likert scale) post intervention. Range 0-10 (higher scores indicate more acceptability). Questionnaire will be administered to youth with chronic pain.
Conditions Studied
Interventions
- BEHAVIORAL Sensory Training
Study Locations (1)
California
- Stanford Pediatric Pain Clinic - Menlo Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2025-01-17 |
| Phase | NA |
What the finished NCT06051305 record still lists
NCT06051305 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Persistent Pain appearing as the primary indexed condition, and to 1 intervention - of which Sensory Training is the first listed.
NCT06051305 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06051305 about?
NCT06051305 is a clinical study titled "Flexible Attention Sensory Training for Youth with Chronic Pain". The purpose of this study is to determine the feasibility and acceptability of gamified sensory rehabilitation training technology for children with chronic musculoskeletal pain.
What is the current status of trial NCT06051305?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2023-10-16. Estimated completion is 2025-01-17.
What conditions does trial NCT06051305 study?
This clinical trial studies the following conditions: Persistent Pain.
What interventions are being tested in trial NCT06051305?
The interventions under investigation include: Sensory Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06051305?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06051305 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06051305's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI